Cargando…
Quantitative Proteomic Analysis of Niemann-Pick Disease, Type C1 Cerebellum Identifies Protein Biomarkers and Provides Pathological Insight
Niemann-Pick disease, type C1 (NPC1) is a fatal, neurodegenerative disorder for which there is no definitive therapy. In NPC1, a pathological cascade including neuroinflammation, oxidative stress and neuronal apoptosis likely contribute to the clinical phenotype. While the genetic cause of NPC1 is k...
Autores principales: | Cologna, Stephanie M., Jiang, Xiao-Sheng, Backlund, Peter S., Cluzeau, Celine V. M., Dail, Michelle K., Yanjanin, Nicole M., Siebel, Stephan, Toth, Cynthia L., Jun, Hyun-sik, Wassif, Christopher A., Yergey, Alfred L., Porter, Forbes D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3483225/ https://www.ncbi.nlm.nih.gov/pubmed/23144710 http://dx.doi.org/10.1371/journal.pone.0047845 |
Ejemplares similares
-
Characterization of hydroxypropyl-beta-cyclodextrins used in the treatment of Niemann-Pick Disease type C1
por: Yergey, Alfred L., et al.
Publicado: (2017) -
Correction: Characterization of hydroxypropyl-beta-cyclodextrins used in the treatment of Niemann-Pick Disease type C1
por: Yergey, Alfred L., et al.
Publicado: (2018) -
Defective Cytochrome P450-Catalysed Drug Metabolism in Niemann-Pick Type C Disease
por: Nicoli, Elena-Raluca, et al.
Publicado: (2016) -
Identification of Novel Pathways Associated with Patterned Cerebellar Purkinje Neuron Degeneration in Niemann-Pick Disease, Type C1
por: Martin, Kyle B., et al.
Publicado: (2019) -
Necroptosis in Niemann–Pick disease, type C1: a potential therapeutic target
por: Cougnoux, A, et al.
Publicado: (2016)